Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
Income Statement
Earnings Waterfall
Tibet Rhodiola Pharmaceutical Holding Co
Revenue
|
3.1B
CNY
|
Cost of Revenue
|
-158.7m
CNY
|
Gross Profit
|
3B
CNY
|
Operating Expenses
|
-1.8B
CNY
|
Operating Income
|
1.2B
CNY
|
Other Expenses
|
-424m
CNY
|
Net Income
|
800.9m
CNY
|
Income Statement
Tibet Rhodiola Pharmaceutical Holding Co
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
1 402
N/A
|
1 465
+4%
|
1 547
+6%
|
1 647
+7%
|
1 668
+1%
|
1 762
+6%
|
1 820
+3%
|
1 678
-8%
|
1 383
-18%
|
1 013
-27%
|
720
-29%
|
666
-8%
|
797
+20%
|
946
+19%
|
980
+4%
|
947
-3%
|
916
-3%
|
883
-4%
|
933
+6%
|
1 014
+9%
|
1 028
+1%
|
1 112
+8%
|
1 194
+7%
|
1 218
+2%
|
1 256
+3%
|
1 256
0%
|
1 266
+1%
|
1 314
+4%
|
1 373
+4%
|
1 571
+14%
|
1 782
+13%
|
1 945
+9%
|
2 139
+10%
|
2 300
+8%
|
2 444
+6%
|
2 535
+4%
|
2 555
+1%
|
2 805
+10%
|
3 032
+8%
|
2 964
-2%
|
3 134
+6%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(1 129)
|
(1 170)
|
(1 240)
|
(1 320)
|
(1 330)
|
(1 417)
|
(1 441)
|
(1 287)
|
(938)
|
(568)
|
(262)
|
(135)
|
(189)
|
(251)
|
(279)
|
(265)
|
(240)
|
(241)
|
(238)
|
(241)
|
(207)
|
(223)
|
(226)
|
(218)
|
(208)
|
(230)
|
(225)
|
(219)
|
(196)
|
(206)
|
(216)
|
(232)
|
(226)
|
(239)
|
(224)
|
(200)
|
(205)
|
(186)
|
(187)
|
(187)
|
(159)
|
|
Gross Profit |
273
N/A
|
295
+8%
|
307
+4%
|
327
+7%
|
339
+3%
|
345
+2%
|
379
+10%
|
391
+3%
|
445
+14%
|
445
0%
|
458
+3%
|
531
+16%
|
608
+15%
|
695
+14%
|
701
+1%
|
682
-3%
|
675
-1%
|
642
-5%
|
695
+8%
|
774
+11%
|
821
+6%
|
889
+8%
|
968
+9%
|
1 000
+3%
|
1 048
+5%
|
1 026
-2%
|
1 041
+1%
|
1 095
+5%
|
1 177
+7%
|
1 365
+16%
|
1 566
+15%
|
1 713
+9%
|
1 913
+12%
|
2 062
+8%
|
2 220
+8%
|
2 334
+5%
|
2 350
+1%
|
2 619
+11%
|
2 844
+9%
|
2 778
-2%
|
2 976
+7%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(258)
|
(276)
|
(281)
|
(294)
|
(311)
|
(321)
|
(348)
|
(356)
|
(374)
|
(360)
|
(360)
|
(384)
|
(414)
|
(455)
|
(453)
|
(453)
|
(420)
|
(374)
|
(405)
|
(416)
|
(510)
|
(651)
|
(697)
|
(757)
|
(706)
|
(618)
|
(630)
|
(660)
|
(720)
|
(890)
|
(1 023)
|
(1 137)
|
(1 338)
|
(1 893)
|
(2 101)
|
(2 156)
|
(1 656)
|
(2 039)
|
(2 065)
|
(1 921)
|
(1 751)
|
|
Selling, General & Administrative |
(250)
|
(267)
|
(272)
|
(286)
|
(299)
|
(314)
|
(342)
|
(349)
|
(359)
|
(360)
|
(361)
|
(385)
|
(399)
|
(454)
|
(451)
|
(453)
|
(441)
|
(426)
|
(457)
|
(496)
|
(557)
|
(584)
|
(629)
|
(656)
|
(693)
|
(659)
|
(671)
|
(705)
|
(757)
|
(884)
|
(1 014)
|
(1 113)
|
(1 268)
|
(1 366)
|
(1 466)
|
(1 533)
|
(1 548)
|
(1 685)
|
(1 818)
|
(1 793)
|
(1 896)
|
|
Research & Development |
0
|
0
|
0
|
0
|
(3)
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
(8)
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
(8)
|
(11)
|
(13)
|
(16)
|
(9)
|
(9)
|
(10)
|
(7)
|
(7)
|
(8)
|
(10)
|
(23)
|
(57)
|
(69)
|
(133)
|
(122)
|
(83)
|
(83)
|
(19)
|
(17)
|
(15)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
(7)
|
0
|
0
|
0
|
(7)
|
0
|
0
|
0
|
(5)
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
(7)
|
0
|
0
|
0
|
(6)
|
0
|
0
|
0
|
(15)
|
0
|
0
|
0
|
(30)
|
0
|
0
|
0
|
(26)
|
|
Other Operating Expenses |
(8)
|
(9)
|
(9)
|
(8)
|
(3)
|
(7)
|
(7)
|
(8)
|
(3)
|
(0)
|
1
|
1
|
(2)
|
0
|
(2)
|
(1)
|
29
|
52
|
52
|
80
|
60
|
(56)
|
(56)
|
(84)
|
3
|
50
|
51
|
52
|
50
|
2
|
1
|
(1)
|
2
|
(458)
|
(502)
|
(501)
|
6
|
(271)
|
(229)
|
(112)
|
186
|
|
Operating Income |
15
N/A
|
19
+29%
|
26
+35%
|
33
+27%
|
27
-18%
|
24
-12%
|
31
+30%
|
35
+12%
|
71
+104%
|
85
+19%
|
97
+15%
|
147
+51%
|
194
+33%
|
240
+24%
|
248
+3%
|
229
-8%
|
256
+12%
|
268
+5%
|
290
+8%
|
358
+23%
|
312
-13%
|
238
-23%
|
271
+14%
|
244
-10%
|
343
+41%
|
407
+19%
|
411
+1%
|
435
+6%
|
458
+5%
|
475
+4%
|
543
+14%
|
576
+6%
|
575
0%
|
169
-71%
|
119
-30%
|
178
+50%
|
694
+289%
|
581
-16%
|
779
+34%
|
857
+10%
|
1 225
+43%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(6)
|
(5)
|
(6)
|
(4)
|
5
|
2
|
5
|
34
|
36
|
35
|
29
|
(3)
|
(4)
|
(9)
|
(36)
|
(42)
|
(42)
|
(39)
|
(5)
|
3
|
10
|
7
|
6
|
11
|
9
|
9
|
12
|
14
|
15
|
29
|
13
|
1
|
140
|
109
|
115
|
121
|
(11)
|
23
|
39
|
49
|
(145)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
(7)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(77)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(458)
|
0
|
0
|
0
|
(219)
|
0
|
(0)
|
(0)
|
(181)
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
|
Total Other Income |
21
|
21
|
22
|
22
|
0
|
1
|
(1)
|
(1)
|
(0)
|
(1)
|
18
|
17
|
33
|
29
|
8
|
59
|
48
|
52
|
56
|
6
|
0
|
0
|
1
|
0
|
1
|
0
|
(0)
|
(1)
|
(2)
|
(1)
|
0
|
(0)
|
(2)
|
(2)
|
(3)
|
(3)
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
|
Pre-Tax Income |
30
N/A
|
36
+20%
|
42
+16%
|
51
+22%
|
27
-48%
|
27
+1%
|
35
+32%
|
68
+92%
|
106
+57%
|
119
+12%
|
144
+21%
|
161
+12%
|
222
+38%
|
259
+17%
|
220
-15%
|
245
+12%
|
262
+7%
|
280
+7%
|
340
+21%
|
367
+8%
|
244
-33%
|
246
+1%
|
277
+12%
|
255
-8%
|
353
+38%
|
416
+18%
|
423
+2%
|
448
+6%
|
470
+5%
|
503
+7%
|
557
+11%
|
577
+4%
|
255
-56%
|
276
+8%
|
231
-16%
|
296
+28%
|
463
+56%
|
603
+30%
|
817
+36%
|
905
+11%
|
898
-1%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(6)
|
(7)
|
(9)
|
(9)
|
(6)
|
(5)
|
(10)
|
(12)
|
(16)
|
(17)
|
(15)
|
(15)
|
(23)
|
(25)
|
(22)
|
(28)
|
(27)
|
(32)
|
(35)
|
(37)
|
(26)
|
(26)
|
(30)
|
(27)
|
(35)
|
(41)
|
(43)
|
(46)
|
(50)
|
(53)
|
(57)
|
(61)
|
(42)
|
(45)
|
(53)
|
(58)
|
(88)
|
(98)
|
(107)
|
(114)
|
(88)
|
|
Income from Continuing Operations |
24
|
29
|
34
|
42
|
20
|
22
|
26
|
56
|
91
|
102
|
129
|
146
|
199
|
234
|
197
|
217
|
234
|
248
|
305
|
330
|
218
|
220
|
247
|
228
|
317
|
375
|
380
|
402
|
421
|
450
|
500
|
515
|
213
|
231
|
178
|
238
|
375
|
505
|
710
|
792
|
810
|
|
Income to Minority Interest |
3
|
4
|
4
|
2
|
1
|
(0)
|
(1)
|
(2)
|
1
|
1
|
0
|
(1)
|
(1)
|
(2)
|
(3)
|
(2)
|
(5)
|
(4)
|
(4)
|
(4)
|
(3)
|
(3)
|
(4)
|
(4)
|
(5)
|
(5)
|
(5)
|
(4)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(5)
|
(5)
|
(5)
|
(6)
|
(6)
|
(9)
|
(9)
|
|
Net Income (Common) |
27
N/A
|
33
+19%
|
38
+16%
|
44
+18%
|
21
-53%
|
21
+0%
|
25
+18%
|
54
+119%
|
92
+68%
|
103
+13%
|
129
+25%
|
145
+13%
|
198
+36%
|
232
+17%
|
195
-16%
|
215
+10%
|
230
+7%
|
244
+6%
|
301
+23%
|
326
+8%
|
216
-34%
|
218
+1%
|
243
+12%
|
224
-8%
|
312
+40%
|
370
+19%
|
375
+1%
|
398
+6%
|
418
+5%
|
447
+7%
|
496
+11%
|
512
+3%
|
209
-59%
|
226
+8%
|
173
-24%
|
233
+35%
|
370
+59%
|
498
+35%
|
703
+41%
|
782
+11%
|
801
+2%
|
|
EPS (Diluted) |
0.14
N/A
|
0.17
+21%
|
0.19
+12%
|
0.22
+16%
|
0.1
-55%
|
0.1
N/A
|
0.12
+20%
|
0.26
+117%
|
0.45
+73%
|
0.51
+13%
|
0.63
+24%
|
0.72
+14%
|
0.97
+35%
|
0.92
-5%
|
0.77
-16%
|
0.85
+10%
|
0.91
+7%
|
0.97
+7%
|
1.19
+23%
|
1.29
+8%
|
0.86
-33%
|
0.86
N/A
|
0.98
+14%
|
0.9
-8%
|
1.25
+39%
|
1.5
+20%
|
1.51
+1%
|
1.61
+7%
|
1.69
+5%
|
1.8
+7%
|
2
+11%
|
2.06
+3%
|
0.84
-59%
|
0.91
+8%
|
0.7
-23%
|
0.94
+34%
|
1.49
+59%
|
2.01
+35%
|
2.84
+41%
|
3.16
+11%
|
3.23
+2%
|